BioMed Research International / 2018 / Article / Tab 4 / Research Article
Chemoradiotherapy as Definitive Treatment for Elderly Patients with Head and Neck Cancer Table 4 Univariate and multivariate analysis of clinicopathological parameters regarding overall survival (OS), progression-free survival (PFS), local control rate (LCR), and distant metastasis-free survival (DMFS);
for 135/158 patients available;
for 116/158 patients available.
Categories Univariate analysis OS PFS LCR DMFS HR CI 95% p valueHR CI 95% p valueHR CI 95% p valueHR CI 95% p valuep16 status; neg/po 1.65 0.83–3.28 0.153 2.351 0.996–5.548 0.051 2.088 0.811–5.371 0.127 6.044 0.806–45.305 0.08 Smoker/non 1.846 1.054–3.233 0.032 1.503 0.777–2.906 0.226 1.387 0.664–2.895 0.384 2.840 1.029–7.835 0.044 Sex male/female 1.008 0.577–1.763 0.977 1.271 0.691–2.339 0.44 1.004 0.496–2.035 0.99 1.364 0.532–3.496 0.518 T3-4/T1-2 1.125 0.453–2.792 0.8 1.192 0.430–3.303 0.736 1.068 0.331–3.453 0.912 2.474 0.730–8.369 0.146 N3/N2/N0-1 2.004 1.098–3.659 0.024 2.002 1.008–3.974 0.047 1.498 0.732–3.062 0.268 3.104 1.016–9.483 0.047 G3/G2/G1 0.75 0.480–1.172 0.206 0,869 0.511–1.478 0.604 0,804 0.445–1.454 0.471 1.518 0.680–3.387 0.309 ECOG2-3/ECOG0-1 2.303 1258–4.129 0.005 2.092 1.060–4.129 0.033 2.589 1.246–5.380 0.011 1.550 0.521–4.615 0.431 Age < 65/≥65 0.895 0.558–1.436 0.646 1.310 0.737–2.327 0.357 1.131 0.606–2.110 0.699 0.651 0.255–1.666 0.371 Age < 70/≥70 0.912 0.524–1.589 0.746 1.057 0.545–2.049 0.871 0.892 0.441–1.806 0.751 0.59 0.174–1.994 0.396 Age < 75/≥75 0.87 0.417–1.814 0.71 1.069 0.426–2.684 0.887 0.833 0.328–2.115 0.701 0.918 0.214–3.932 0.909 Categories Multivariate analysis OS PFS LCR DMFS HR CI 95% p valueHR CI 95% p valueHR CI 95% p valueHR CI 95% p valueSmoker/nonsmoke 2.321 1.287–4.183 0.005 3.222 1.130–9.189 0.029 N3/N2/N0-1 2.356 0.947–5.863 0.066 1.819 0.859–3.852 0.118 6.890 1.479–32.109 0.014 ECOG2-3/ECOG0-1 2.573 1.344–4.928 0.004 1.990 1.007–3.933 0.048